School of Medicine
Showing 21-40 of 788 Results
-
Alex Macario MD MBA
Professor of Anesthesiology, Perioperative and Pain Medicine and, by courtesy, of Health Research and Policy at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Macario studies health care economics & outcomes, with a special focus on surgery and anesthesia. He is well known for helping develop the field of operating room management, and is keenly interested in the cost-effectiveness analyses of drugs and devices. For the past decade Dr. Macario has added medical education as a research priority to better understand methods to best teach students and residents. Google Scholar calculates Dr. Macario?s H-Index as 45 and his I-10 as 99.
-
Kathryn S. Macia
Postdoctoral Research Fellow, Psychiatry
Bio Kathryn Macia is a postdoctoral fellow with the National Center for PTSD, Dissemination & Training Division at VA Palo Alto Health Care System, the VA Office of Academic Affiliations' Advanced Fellowship Program in Mental Illness Research and Treatment, and the Department of Psychiatry and Behavioral Sciences at Stanford University. Her research and interests focus on traumatic stress, emotion regulation, interpersonal/social factors, homelessness, and substance use among veterans and vulnerable populations, as well as advanced statistical methods.
-
M Bruce MacIver
Professor (Research) of Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly Interests We study drug effects on the nervous system. Cellular, synaptic and molecular drug actions are investigated using electrophysiological and pharmacological tools in cortical/hippocampal brain slice preparations. We are also interested in mechanisms of neuronal integration and synchronization, especially related to patterns of EEG activity seen in vivo and in brain slices.
-
Crystal Mackall
Ernest and Amelia Gallo Family Professor and Professor of Pediatrics and of Medicine
Current Research and Scholarly Interests Recent clinical studies, by us and others, have demonstrated that T cell based immunotherapy can eradicate cancers resistant to all other available therapies. Our program creates, develops and optimizes genetically engineered T cells to treat cancer. We link the bench with the bedside, developing novel therapies for early phase testing in clinical trials, while simultaneously conducting intensive studies on clinical samples obtained from patients treated on immunotherapy trials.
